In the Stroke + Semax group, analogous to the effects of Mexidol, we observed a statistically significantly increased level of PGC-1α (by 20%, p < 0.01) compared to the Stroke + Saline group in the acute and delayed post-ischemic periods (Figure 6A). This evidence concerns the gene PPARGC1A and Stroke.